RxDoctor Payments Data

Matthew Ralsten, MD

Obstetrics & Gynecology · Fayetteville, GANPI 1184654394

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $43,000 of the $64,435 with a category attached, or 66.7%. Applied Medical Resources Corporation accounts for 80.5% of it on its own, with 42 other manufacturers making up the rest. Reporting peaked in 2022 at $18,916 and has fallen 83.0% since, to $3,221 in 2025. Among obstetrics & gynecology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$64,435in general payments, 2019–2025

Across 329 payments — averaging $195.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Applied Medical Resources Corporation$52K
  • Intuitive Surgical$4K
  • Minerva Surgical, Inc$3K
  • Momentis Surgical Inc.$1K
  • AbbVie$767
  • Mayne Pharma Commercial LLC$660
  • plus $4K from 37 others

What the payments were for

  • Consulting fees$2,2503%
  • Speaking & faculty fees$43,00067%
  • Travel & lodging$10,62016%
  • Food & beverage$6,96911%
  • Education$1,5962%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$64,435 in reported general payments places this provider in the 95th percentile of 1,324 obstetrics & gynecology providers in Georgia.

See all obstetrics & gynecology providers in Georgia

Medicare billing

Part B allowed, 2024
$17,727
Medicare patients
93
Services billed
174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OsphenaOspemifene15$10,200
PremarinEstrogens, Conjugated18$8,249
Estradiol67$3,419
ValacyclovirValacyclovir Hcl18$736
Oxybutynin Chloride ErOxybutynin Chloride22$653
ProgesteroneProgesterone, Micronized14$394
Clobetasol Propionate11$376
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$207
Fluconazole11$33

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Duchesnay USA IncorporatedOsphena$17$10,20015 claims
PfizerPremarin$86$8,24918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,324 obstetrics & gynecology providers in Georgia.

Other obstetrics & gynecology in Fayetteville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →